Jordan vs South-East Asia (WHO region): Diabetes treatment coverage, crude
Jordan
70.95
in 2022
South-East Asia (WHO region)
28.37
in 2022
Jordan rank
8th
South-East Asia (WHO region) rank
9th
Diabetes treatment coverage, crude over time
- Jordan
- South-East Asia (WHO region)
How they compare
Jordan currently reports 70.95 against 28.37 in South-East Asia (WHO region), a difference of 42.58.
That makes Jordan's figure about 2.5 times South-East Asia (WHO region)'s.
Across all 33 years both countries report, Jordan has been ahead every year.
Jordan ranks 8th and South-East Asia (WHO region) ranks 9th of 198 countries.
Jordan has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Jordan | South-East Asia (WHO region) | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 41.38 | 23.2 | 18.19 | Jordan |
| 2000s | 48.89 | 24.29 | 24.61 | Jordan |
| 2010s | 62.3 | 26.87 | 35.43 | Jordan |
| 2020s | 69.9 | 28.21 | 41.69 | Jordan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher diabetes treatment coverage, crude, Jordan or South-East Asia (WHO region)?
- Jordan, at 70.95 against 28.37 in South-East Asia (WHO region) as of 2022.
- What is the difference in diabetes treatment coverage, crude between Jordan and South-East Asia (WHO region)?
- 42.58, with Jordan ahead.
- How many years of comparable data are there for Jordan and South-East Asia (WHO region)?
- 33 years are reported by both, from 1990 to 2022.
- How do Jordan and South-East Asia (WHO region) rank globally for diabetes treatment coverage, crude?
- Jordan ranks 8th and South-East Asia (WHO region) ranks 9th of 198 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Diabetes treatment coverage, crude. Statizoid refreshes it automatically from the source and publishes the full history for both places.